ProQR Therapeutics N.V.
PRQR
$1.98
$0.031.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 125.41M | 140.65M | 143.12M | 154.68M | 99.71M |
| Total Receivables | 2.99M | 2.85M | 2.98M | 2.10M | 1.46M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.23M | 2.45M | 3.15M | 2.50M | 1.91M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 130.62M | 145.95M | 149.24M | 159.28M | 103.07M |
|
|
|||||
| Total Current Assets | 130.62M | 145.95M | 149.24M | 159.28M | 103.07M |
| Net Property, Plant & Equipment | 15.27M | 15.57M | 14.71M | 14.61M | 16.10M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 145.90M | 161.52M | 163.95M | 173.89M | 119.17M |
|
|
|||||
| Total Accounts Payable | 357.90K | 1.51M | 447.50K | 16.60K | 34.60K |
| Total Accrued Expenses | 142.00K | 330.00K | 519.90K | 1.53M | 1.53M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.60M | 7.49M | 6.61M | 6.37M | 6.58M |
| Total Finance Division Other Current Liabilities | 30.78M | 29.53M | 28.87M | 32.36M | 36.07M |
| Total Other Current Liabilities | 30.78M | 29.53M | 28.87M | 32.36M | 36.07M |
| Total Current Liabilities | 38.88M | 38.86M | 36.44M | 40.28M | 44.21M |
|
|
|||||
| Total Current Liabilities | 38.88M | 38.86M | 36.44M | 40.28M | 44.21M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 11.75M | 12.31M | 11.61M | 11.46M | 12.83M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 28.31M | 31.69M | 30.59M | 30.47M | 34.27M |
| Total Liabilities | 78.94M | 82.86M | 78.64M | 82.20M | 91.31M |
|
|
|||||
| Common Stock & APIC | 572.79M | 573.33M | 85.32M | 505.35M | 464.46M |
| Retained Earnings | -538.20M | -525.86M | -- | -442.24M | -466.23M |
| Treasury Stock & Other | 32.37M | 31.20M | -- | 28.57M | 29.63M |
| Total Common Equity | 66.96M | 78.66M | 85.32M | 91.69M | 27.86M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 66.96M | 78.66M | 85.32M | 91.69M | 27.86M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 66.96M | 78.66M | 85.32M | 91.69M | 27.86M |
|
|
|||||